Tenet Healthcare Lifts 2026 EBITDA Outlook on Stronger USPI Growth

EarningsCorporate Action

โดย Zacks Investment Research·

Summary · why it matters

Tenet Healthcare has raised its 2026 adjusted EBITDA outlook to $4.83-$5.03 billion, citing higher-acuity services, strong commercial revenues and continued expansion of its ambulatory care platform, USPI. The Zacks Consensus Estimate for Tenet Healthcare's 2026 earnings is pegged at $21.04 per share, indicating a 25.4% year-over-year rise, while the consensus mark for revenues is pinned at $22.2 billion, indicating 4.2% year-over-year growth. In the second quarter of 2026, same-hospital adjusted admissions increased 2.6% year over year and same-hospital net patient service revenues per adjusted admission rose 3.3%, while USPI revenues grew 9.3% to $1.4 billion and surgical business same-facility system-wide net patient service revenues grew 5%. The company repurchased $1 billion of shares in the second quarter of 2026 and its board expanded the share repurchase authorization by $2 billion, leaving approximately $2.1 billion remaining as of July 23, 2026. Tenet Healthcare expects to exceed $300 million of ambulatory M&A spending in 2026, and its operating expenses rose 2.1% year over year in the second quarter of 2026 on elevated labor costs, higher medical supplies and increased patient acuity.

Tenet Healthcare Corporation ▲